NIH-funded research R01 grant

Genes behind abdominal aortic aneurysm

Official title: Using genetics to discover mechanisms of abdominal aortic aneurysm

Funded at University of Michigan at Ann Arbor · NIH-11161577 · Data updated 2026-11-12

Researchers will use large-scale genetic and tissue data to find genes and biological signals that could help prevent or treat abdominal aortic aneurysms in people at risk.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startAugust 18, 2011
Project endMay 31, 2028
Funding year2025
Award (this year)$779,872
NIH project number5R01HL109946-11
Project IDNIH-11161577 on NIH RePORTER

Who could benefit from this research

Could help

People with abdominal aortic aneurysm, a strong family history of AAA, or who are enrolled in a contributing biobank or cardiovascular genetics study would be most relevant to this work.

Less likely to help

People without AAA-related conditions, those unwilling to provide genetic or tissue samples, or patients seeking immediate therapeutic benefit should not expect direct benefit from this research.

What this research studies

This project combines genetic data from large international cohorts to increase the number of people studied and find genetic regions linked to abdominal aortic aneurysm (AAA). The team will fine-map those regions using bioinformatics and multi-omics data from abdominal aorta tissue to prioritize likely causal genes. Top candidate genes will be tested in cell culture and animal models to understand how they affect aortic biology. Researchers from genetics, computational biology, and cardiovascular medicine aim to turn genetic signals into prevention or treatment targets.

Why it matters

Potential benefit: If successful, the work could reveal biological targets that lead to earlier detection, prevention strategies, or new treatments for AAA.

How similar studies have gone: Similar genetics and multi-omics approaches have identified risk genes for coronary artery disease and atrial fibrillation, but applying these methods to AAA is relatively new and remains exploratory.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Chen, Yuqing Eugene — University of Michigan at Ann Arbor
  • Study coordinator: Chen, Yuqing Eugene

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.